DB Surgical Announces New Office Expansion


Coral Springs, FL – October 23, 2018 – DB Surgical, a business specializing in the distribution of surgical technology, today announced plans to expand its office space at its Coral Springs location. DB Surgical will now occupy Suites One and Two at 12480 W. Atlantic Blvd. The expanded space, spanning 3,000 square feet, will feature additional private offices, collaboration rooms, and storage space. DB Surgical is adding on this additional space to facilitate continued growth by increasing its capacity to:

  • Stock inventory close to customers
  • Conduct product trainings on newly introduced medical devices
  • Attract and retain top talent for its Coral Springs based operations team

“Our expanded Coral Springs office deepens DB Surgical’s commitment to bringing transformational surgical technologies to hospitals and surgery centers,” said Debbie Burg, President of DB Surgical. “Even more important than the features of our products are our people. They are the backbone of our success in meeting rising demand.” Continual reinvestment in its infrastructure and team is central to DB Surgical’s mission of supporting customers by introducing tools and services that enable surgeons to advance patient outcomes.


About DB Surgical – DB Surgical is dedicated to bringing transformational surgical technologies to hospitals and surgery centers. The company focuses on introducing tools that enable surgeons to advance patient outcomes beyond those available today. Since 1997, DB Surgical has worked with industry-leading surgeons to understand and meet the evolving needs of healthcare providers. The company is based in Coral Springs, FL and has 19 professionals located throughout Florida, Georgia, and Alabama focusing on the Neuro, Spine, ENT, Cardiovascular, Ophthalmic, and Plastic Reconstructive surgical disciplines. In addition to providing cutting-edge technologies, DB Surgical also offers a complete line of specialty surgical products designed to create value within the healthcare supply chain. More information is available at www.DBSurgical.com.


Contact DB Surgical for more information.

Microscope Imaging System Integrates Virtual Reality Technology

VIDEO: Joshua Bederson, M.D., utilizes the latest simulation and virtual reality advances during neurosurgery.
Credit: Mount Sinai Health System


Joshua Bederson, MD, Professor and System Chair for the Department of Neurosurgery at Mount Sinai Health System, is the first neurosurgeon to use CaptiView – a microscope image injection system from Leica Microsystems that overlays critical virtual reality imaging directly onto the brain when viewed through the eyepiece, known as the ocular, during surgery. This new microscope technology allows images of chosen objects, including original CT, MRI and angiogram datasets, to be superimposed, or ‘injected,’ directly into the neurosurgeon’s eyepiece during microscopic surgery.

“This next-generation augmented virtual reality tool provides real-time information in ways never before realized,” says Dr. Bederson, who is now using the technology for all of his cases. He worked closely with Leica Microsystems and Brainlab® to develop the surgical navigation tool.

The CaptiView image injection system utilizes Brainlab® Cranial 3.1 Navigation Software in conjunction with a Leica M530 OH6 microscope. The heads-up display provides neurovascular and fiber-track information in 2D or 3D as well as on-screen video overlays visible through the ocular. The microscope integration also allows the surgeon to switch views in the eyepiece, toggling between live and pre-operative anatomical images using handle control buttons or footswitch for ease of use and uninterrupted workflow. Markers attached to the microscope enable positional tracking and autofocus.

This new technology will be utilized alongside Surgical Navigation Advanced Platform (SNAP) developed by Surgical Theater, LLC, which is a standard feature in the operating room. SNAP provides advanced 3D visualization technology that gives surgeons an intraoperative and patient-specific 3D environment to plan and understand surgical approaches.

“We are driving and advancing the development of next-generation simulation and virtual reality technology, which can help improve patient outcomes and solve neurosurgical challenges,” says Dr. Bederson.

Dr. Bederson is an expert in skull-base and cerebrovascular surgery and has performed more than 3,600 neurosurgical operations at Mount Sinai. Dr. Bederson owns equity in Surgical Theater, LLC.


Contact DB Surgical for more information.

Republished from EurekAlert!